Sarah Romano - Mar 1, 2022 Form 4 Insider Report for First Wave BioPharma, Inc. (FWBI)

Role
Chief Financial Officer
Signature
/s/ Sarah Romano
Stock symbol
FWBI
Transactions as of
Mar 1, 2022
Transactions value $
$0
Form type
4
Date filed
3/2/2022, 05:02 PM
Previous filing
Feb 11, 2022
Next filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FWBI Stock option (right to buy) Award $0 +150K $0.00 150K Mar 1, 2022 Common stock, par value $0.0001 per share 150K $1.18 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in three equal annual installments commencing on March 1, 2023.